drugset / Trial / NCT04505683

A Study to Assess Efficacy and Safety Intravenous Benapenem in Patients With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)

NCT04505683

Phase 2/3 Completed 112 enrolled Sihuan Pharmaceutical Holdings Group Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

A Study to Assess Efficacy and Safety Intravenous Benapenem in Patients With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)

Timeline

Start
2018-12-13
Primary completion
2020-05-08
Completion
2020-05-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Benapenem Small molecule 1 g Intravenous
Comparator Ertapenem Small molecule 1 g Intravenous

Indications